Clinical Trial Update: RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer

View source ↗

Summary

This document reports the completion of a clinical trial evaluating RaFIST, a radiomics-based tool for stratifying intratumoral fibrosis in non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jinling Hospital, China | Conditions: Lung Cancer - Non Small Cell | Status: COMPLETED